Q4 2024 Holdings
Filed 2025-02-14 | 21 holdings | $185.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-05-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $32.5M | 1,131,501 | 17.5% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $22.4M | 2,861,825 | 12.1% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $16.8M | 1,939,644 | 9.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $16.1M | 1,516,303 | 8.7% |
| Puma Biotechnology Inc(PBYI)A | COM | 74587V107 | $12.0M | 3,940,052 | 6.5% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $11.2M | 643,381 | 6.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $10.9M | 1,971,264 | 5.9% |
| Onkure Therapeutics Inc(OKUR) | CLASS A COM | 68277Q105 | $10.2M | 1,439,674 | 5.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $8.2M | 2,001,048 | 4.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.8M | 1,279,800 | 3.6% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $6.5M | 734,393 | 3.5% |
| Cardif Oncology Inc(CRDF) | COM | 14147L108 | $6.3M | 1,442,308 | 3.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.4M | 7,310,650 | 2.9% |
| Mural Oncology PLC | COM | G63365103 | $4.1M | 1,286,079 | 2.2% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $3.6M | 1,147,052 | 1.9% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $2.8M | 422,813 | 1.5% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $2.8M | 803,425 | 1.5% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $2.4M | 405,237 | 1.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $2.4M | 4,032,046 | 1.3% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.5M | 456,970 | 0.8% |
| Verastem Inc(VSTM)A | COM NEW | 92337C203 | $779.5K | 779,498 | 0.4% |